DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Brooks DJ, Agid Y, Eggert K. TC-INIT Study Group.
Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
Eur Neurol 2005; 53: 197-202
We do not assume any responsibility for the contents of the web pages of other providers.